
A world-first clinical trial has been launched in the UK for a fridge-free vaccine, which could greatly increase access to jabs.
The Stablepharma tetanus-diphtheria vaccine (SPVX02) is completely stable at room temperature and the firm behind it says up to 60 other vaccines may benefit from the advanced technology.